EFFECT OF NATURAL PRODUCTS ON THE ATHEROGENIC MODIFICATION OF LDL


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Modified low-density lipoproteins (LDL) stimulate cholesterol accumulation in the cells of blood vessels, favoring the development of atherosclerosis. The enzyme trans-sialidase induces atherogenic modification of LDL. This investigation has studied the effect of extracts from natural products on plasma trans-sialidase activity.

全文:

受限制的访问

作者简介

I. Azarova

Institute for Atherosclerosis Research

Email: irina.nik.azarova@gmail.com

A. Feoktlstov

Institute for Atherosclerosis Research

Candidate of Biological Sciences

A. Orekhov

Institute for Atherosclerosis Research; Research Institute of General Pathology and Pathophysiology

Professor

参考

  1. Orekhov A., Tertov V., Mukhin D. Desialylated low density lipoprotein -naturally occurring lipoprotein with atherogenic potency // Atherosclerosis. - 1991; 86: 153-61.
  2. Orekhov A., Tertov V., Mukhin D. et al. Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells. Discovery of desialylated lipoprotein with altered cellular metabolism in the blood of atherosclerotic patients // Biochem. Biophys. Res. Commun. - 1989; 162: 206-11.
  3. Lowry O., Rosebrough N., Farr A. et al. Protein measurement with the Folin phenol reagent // J. Biol. Chem. - 1951; 193: 265-75.
  4. Millar J. The sialylation of plasma lipoproteins // Atherosclerosis. - 2011; 154: 1-13.
  5. Tertov V., Kaplun V., Sobenin I. et al. Human plasma trans-sialidase causes atherogenic modification of low density lipoprotein // Atherosclerosis. - 2001; 159: 103-15.
  6. Tertov V., Sobenin I., Tonevitsky A. et al. Isolation of atherogenic modified (desialylated) low density lipoprotein from blood of atherosclerotic patients: separation from native lipoprotein by affinity chromatography // Biochem. Biophys. Res. Commun. - 1990; 167: 1122-7.
  7. Taniguchi T., Ishikava Y., Tsunemitsu M. et al. Stimulation of cholesteryl ester synthesis in human monocyte-derived macrophages by asialo low density lipoproteins // Arteriosclerosis. - 1989; 9: 767.
  8. Tertov V., Kaplun V., Sobenin I. et al. Low-density lipoprotein modification occurring in human plasma. Possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification // Atherosclerosis. - 1998; 138: 183-95.
  9. Veh R., Corfield A., Sander M. et al. Neuraminic acid-specific modification and tritium labelling of gangliosides // Biochem. Biophys. Acta. - 1977; 486: 145-60.
  10. Dixon W., Brown M. Biomedical Computer Programs. P-Series. University of California Press, Berkeley. 1977; 185-203.
  11. Schenkman S. Structural and functional properties of trypanosoma transsialidase // Annu. Rev. Microbiol. - 1994; 48: 499-523.
  12. Agusti R., Paris G., Ratier L. et al. Lactose derivatives are inhibitors of Trypanosoma crusi trans-sialidase activity toward conventional substrates in vitro and in vivo // Glycobiology. - 2004; 14 (7): 659-70.
  13. Tertov V., Orekhov A., Sobenin I. et al. Carbohydrate content of protein and lipid components in sialic acid-rich and -poor low density lipoptoteins from subjects with and without coronary artery disease // J. Lipid. Res. - 1993; 34: 365-75.

补充文件

附件文件
动作
1. JATS XML
下载
##common.cookie##